Nifty
Sensex
:
:
24363.30
79857.79
-232.85 (-0.95%)
-765.47 (-0.95%)

Pharmaceuticals & Drugs - Domestic

Rating :
66/99

BSE: 540596 | NSE: ERIS

1725.20
08-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1688.1
  •  1745.9
  •  1680
  •  1694.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  104058
  •  179097988.8
  •  1910
  •  1097.2

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,430.97
  • 60.54
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 25,629.80
  • 0.43%
  • 7.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.83%
  • 0.34%
  • 9.12%
  • FII
  • DII
  • Others
  • 8.39%
  • 17.42%
  • 9.90%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.10
  • 19.01
  • 19.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.47
  • 18.75
  • 13.64

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.17
  • -0.19
  • -2.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 27.72
  • 26.76
  • 31.28

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.35
  • 5.47
  • 5.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.67
  • 20.19
  • 20.51

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
28.82
25.85
40.77
55.03
P/E Ratio
59.86
66.74
42.32
31.35
Revenue
1991
2879
3375
3868
EBITDA
675
1017
1220
1432
Net Income
392
352
555
753
ROA
7.3
5
9.1
11.4
P/B Ratio
9.30
8.23
6.69
5.68
ROE
16.39
12.93
17.03
19.69
FCFF
287
769
-153
-185
FCFF Yield
1.16
3.13
-0.62
-0.75
Net Debt
1381
2250
1407
610
BVPS
185.55
209.59
257.78
303.98

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
773.00
719.72
7.40%
705.30
550.93
28.02%
727.45
486.30
49.59%
741.17
505.30
46.68%
Expenses
496.29
469.73
5.65%
452.91
402.51
12.52%
477.14
310.79
53.52%
476.66
324.16
47.04%
EBITDA
276.71
249.99
10.69%
252.39
148.42
70.05%
250.31
175.51
42.62%
264.51
181.14
46.03%
EBIDTM
35.80%
34.73%
35.78%
26.94%
34.41%
36.09%
35.69%
35.85%
Other Income
2.69
1.64
64.02%
7.95
15.15
-47.52%
4.22
4.20
0.48%
4.55
3.48
30.75%
Interest
48.68
60.37
-19.36%
54.28
33.03
64.34%
57.17
18.12
215.51%
59.47
16.30
264.85%
Depreciation
70.51
75.74
-6.91%
77.25
53.80
43.59%
81.20
45.72
77.60%
80.48
42.09
91.21%
PBT
160.21
115.52
38.69%
128.81
76.74
67.85%
116.16
115.87
0.25%
129.11
126.23
2.28%
Tax
36.00
25.97
38.62%
26.52
-2.96
-
29.23
14.41
102.85%
32.76
3.93
733.59%
PAT
124.21
89.55
38.70%
102.29
79.70
28.34%
86.93
101.46
-14.32%
96.35
122.30
-21.22%
PATM
16.07%
12.44%
14.50%
14.47%
11.95%
20.86%
13.00%
24.20%
EPS
8.66
6.12
41.50%
6.89
5.22
31.99%
6.14
7.55
-18.68%
6.73
9.08
-25.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
2,946.92
2,893.64
2,009.15
1,685.15
1,347.04
1,211.86
1,074.06
982.16
855.60
749.50
597.02
Net Sales Growth
30.27%
44.02%
19.23%
25.10%
11.15%
12.83%
9.36%
14.79%
14.16%
25.54%
 
Cost Of Goods Sold
718.04
713.99
380.05
352.35
258.51
238.27
171.53
153.70
141.57
133.60
98.48
Gross Profit
2,228.88
2,179.65
1,629.10
1,332.80
1,088.53
973.60
902.53
828.46
714.03
615.90
498.54
GP Margin
75.63%
75.33%
81.08%
79.09%
80.81%
80.34%
84.03%
84.35%
83.45%
82.17%
83.50%
Total Expenditure
1,903.00
1,876.44
1,334.32
1,148.40
862.01
781.11
706.17
637.08
533.49
480.36
425.32
Power & Fuel Cost
-
15.08
12.04
5.70
4.16
3.95
4.62
3.45
3.17
3.02
3.59
% Of Sales
-
0.52%
0.60%
0.34%
0.31%
0.33%
0.43%
0.35%
0.37%
0.40%
0.60%
Employee Cost
-
505.09
403.82
346.16
250.18
229.30
205.69
190.66
157.32
131.22
124.67
% Of Sales
-
17.46%
20.10%
20.54%
18.57%
18.92%
19.15%
19.41%
18.39%
17.51%
20.88%
Manufacturing Exp.
-
45.10
23.89
15.61
38.81
11.51
13.96
7.81
4.89
5.05
7.87
% Of Sales
-
1.56%
1.19%
0.93%
2.88%
0.95%
1.30%
0.80%
0.57%
0.67%
1.32%
General & Admin Exp.
-
261.45
253.91
206.62
154.21
121.70
135.85
142.38
116.86
121.29
104.36
% Of Sales
-
9.04%
12.64%
12.26%
11.45%
10.04%
12.65%
14.50%
13.66%
16.18%
17.48%
Selling & Distn. Exp.
-
291.05
208.45
185.16
121.39
128.70
140.99
134.82
107.67
84.32
82.75
% Of Sales
-
10.06%
10.38%
10.99%
9.01%
10.62%
13.13%
13.73%
12.58%
11.25%
13.86%
Miscellaneous Exp.
-
44.68
52.16
36.80
34.74
47.69
33.53
4.25
2.00
1.86
82.75
% Of Sales
-
1.54%
2.60%
2.18%
2.58%
3.94%
3.12%
0.43%
0.23%
0.25%
0.60%
EBITDA
1,043.92
1,017.20
674.83
536.75
485.03
430.75
367.89
345.08
322.11
269.14
171.70
EBITDA Margin
35.42%
35.15%
33.59%
31.85%
36.01%
35.54%
34.25%
35.13%
37.65%
35.91%
28.76%
Other Income
19.41
18.36
23.82
11.15
26.09
8.71
16.01
31.69
26.41
25.11
3.37
Interest
219.60
231.29
84.80
26.17
4.22
1.98
2.30
23.06
10.65
1.10
0.28
Depreciation
309.44
315.46
182.51
117.09
64.70
42.98
50.26
36.35
25.64
22.76
20.36
PBT
534.29
488.81
431.34
404.64
442.20
394.50
331.35
317.36
312.23
270.39
154.44
Tax
124.51
114.20
34.22
30.48
36.41
39.36
34.84
26.21
17.25
23.78
19.59
Tax Rate
23.30%
23.36%
7.93%
7.53%
8.23%
9.98%
10.51%
8.26%
5.52%
8.79%
12.68%
PAT
409.78
351.84
392.05
382.16
406.11
355.13
296.50
290.80
294.11
246.79
133.57
PAT before Minority Interest
386.10
374.67
397.12
374.16
405.79
355.13
296.51
291.15
294.98
246.61
134.86
Minority Interest
-23.68
-22.83
-5.07
8.00
0.32
0.00
-0.01
-0.35
-0.87
0.18
-1.29
PAT Margin
13.91%
12.16%
19.51%
22.68%
30.15%
29.30%
27.61%
29.61%
34.37%
32.93%
22.37%
PAT Growth
4.27%
-10.26%
2.59%
-5.90%
14.36%
19.77%
1.96%
-1.13%
19.17%
84.76%
 
EPS
30.09
25.83
28.78
28.06
29.82
26.07
21.77
21.35
21.59
18.12
9.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,854.36
2,586.18
2,195.99
1,908.31
1,576.42
1,296.33
1,150.52
861.31
567.14
299.62
Share Capital
13.62
13.60
13.60
13.59
13.58
13.58
13.75
13.75
13.75
0.14
Total Reserves
2,830.65
2,567.56
2,179.59
1,892.82
1,558.87
1,279.90
1,135.57
847.56
553.39
299.49
Non-Current Liabilities
2,100.97
979.35
730.02
-78.80
-109.06
-79.63
-65.50
248.09
11.82
19.84
Secured Loans
1,737.51
654.51
644.45
45.00
0.00
0.00
0.29
274.19
0.49
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
78.97
52.72
44.67
32.16
31.47
25.98
19.39
18.71
22.96
23.10
Current Liabilities
1,489.55
2,608.96
521.18
283.34
235.45
220.17
377.25
293.98
129.27
68.95
Trade Payables
332.35
218.93
124.77
117.77
102.62
100.05
84.13
90.77
38.52
24.57
Other Current Liabilities
530.75
900.18
190.12
35.81
29.07
27.44
198.57
115.06
13.52
9.71
Short Term Borrowings
396.59
1,311.31
55.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
229.86
178.54
151.29
129.75
103.76
92.68
94.55
88.15
77.24
34.67
Total Liabilities
6,862.28
6,810.40
3,471.88
2,112.74
1,702.81
1,436.87
1,480.58
1,428.04
732.02
391.61
Net Block
5,306.48
4,319.16
2,568.10
917.94
853.87
874.85
760.54
771.09
231.65
71.37
Gross Block
6,060.83
4,772.87
2,843.17
1,091.96
1,005.79
983.89
838.26
819.52
254.43
123.31
Accumulated Depreciation
754.35
453.71
275.07
174.02
151.92
109.04
77.73
48.42
22.78
51.95
Non Current Assets
5,531.13
4,431.47
2,629.21
1,401.72
1,167.24
901.78
827.09
1,060.81
462.52
169.38
Capital Work in Progress
67.01
19.67
21.72
26.99
1.55
4.37
2.73
0.00
0.07
0.00
Non Current Investment
62.00
15.55
6.69
420.84
243.65
3.20
40.91
271.61
213.05
62.60
Long Term Loans & Adv.
88.29
69.83
25.32
35.94
25.90
16.47
17.03
12.11
12.84
35.41
Other Non Current Assets
7.35
7.26
7.37
0.00
42.27
2.88
5.88
6.00
4.91
0.00
Current Assets
1,331.15
2,378.93
842.67
711.02
535.56
535.10
653.49
367.23
269.50
222.24
Current Investments
5.00
0.00
30.01
99.55
50.40
74.78
314.94
93.76
90.18
127.44
Inventories
334.83
189.03
131.44
117.91
94.47
69.47
82.65
65.45
55.82
47.62
Sundry Debtors
458.64
422.00
292.71
160.97
140.49
156.88
83.98
66.64
48.86
25.37
Cash & Bank
222.83
1,400.64
58.46
52.33
38.28
67.33
7.51
10.64
2.42
9.69
Other Current Assets
309.85
32.14
22.42
24.04
211.94
166.63
164.41
130.74
72.22
12.11
Short Term Loans & Adv.
282.57
335.12
307.65
256.23
175.70
111.48
106.85
86.48
64.91
9.85
Net Current Assets
-158.40
-230.03
321.49
427.68
300.12
314.93
276.24
73.25
140.22
153.29
Total Assets
6,862.28
6,810.40
3,471.88
2,112.74
1,702.80
1,436.88
1,480.58
1,428.04
732.02
391.62

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
1,065.01
486.01
291.74
378.26
375.36
271.17
223.00
234.63
200.21
131.48
PBT
488.87
431.34
404.64
442.20
394.50
331.35
317.36
312.23
270.39
154.44
Adjustment
548.05
254.16
139.84
49.25
44.07
44.24
30.50
14.12
-0.65
19.92
Changes in Working Capital
125.97
-98.74
-175.54
-29.90
5.33
-52.65
-53.24
-22.15
-16.45
-8.21
Cash after chg. in Working capital
1,162.89
586.76
368.95
461.55
443.90
322.94
294.62
304.20
253.29
166.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-97.88
-100.75
-77.21
-83.28
-68.53
-51.77
-71.63
-69.56
-53.08
-34.68
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-79.97
-1,854.52
-982.10
-319.61
-323.36
123.23
-5.05
-590.10
-184.46
-43.91
Net Fixed Assets
-1,063.66
-716.65
-308.79
-67.95
-18.41
-145.49
-21.60
-419.73
-5.00
-22.68
Net Investments
627.68
-622.44
-218.78
-246.36
-211.07
260.17
-34.87
-164.99
-174.29
-24.03
Others
356.01
-515.43
-454.53
-5.30
-93.88
8.55
51.42
-5.38
-5.17
2.80
Cash from Financing Activity
-881.32
1,379.68
688.02
-44.70
-82.39
-334.59
-221.05
363.21
-23.66
-83.70
Net Cash Inflow / Outflow
103.72
11.17
-2.34
13.96
-30.39
59.81
-3.11
7.75
-7.91
3.87
Opening Cash & Equivalents
94.25
56.02
50.87
36.91
67.31
7.50
10.61
2.34
8.87
5.00
Closing Cash & Equivalent
199.74
94.15
56.02
50.87
36.91
67.31
7.50
10.61
2.34
8.87

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
208.83
189.79
161.28
140.25
115.81
95.26
83.58
62.64
41.25
21711.81
ROA
5.48%
7.72%
13.40%
21.27%
22.62%
20.33%
20.02%
27.31%
43.89%
36.17%
ROE
13.81%
16.64%
18.25%
23.33%
24.78%
24.28%
28.96%
41.30%
56.90%
47.68%
ROCE
13.59%
12.37%
17.30%
25.29%
27.60%
25.44%
26.54%
35.76%
62.56%
54.56%
Fixed Asset Turnover
0.55
0.56
0.90
1.33
1.25
1.18
1.18
1.59
3.97
5.42
Receivable days
54.07
61.68
46.91
39.44
43.59
40.93
27.99
24.64
18.07
14.56
Inventory Days
32.16
27.66
25.78
27.78
24.03
25.85
27.52
25.87
25.19
31.24
Payable days
140.91
165.04
125.63
155.58
155.23
59.47
59.07
54.07
32.17
33.59
Cash Conversion Cycle
-54.68
-75.70
-52.94
-88.36
-87.61
7.30
-3.57
-3.57
11.09
12.21
Total Debt/Equity
0.85
1.06
0.38
0.02
0.00
0.00
0.15
0.44
0.00
0.00
Interest Cover
3.11
6.09
16.46
105.81
200.75
145.25
14.76
30.31
246.14
558.56

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.